Organization

MGC Pharmaceuticals

2 clinical trials

Clinical trial

Randomized, Double Blind, Placebo Controlled, Parallel Design Phase II b Study of Safety and Efficacy of MGCND00EP1 as an Add on Treatment in Children and Adolescents With Resistant Epilepsies

Status: Not yet recruiting, Estimated PCD: 2024-08-01

Clinical trial

A Phase IIb, Double Blind, Placebo-controlled Clinical Study Designed to Evaluate the Effect of CimetrA in Patients Diagnosed With COVID-19

Status: Completed, Estimated PCD: 2023-01-21